These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

358 related articles for article (PubMed ID: 24766894)

  • 1. Inflammasomes and metabolic disorders: old genes in modern diseases.
    Robbins GR; Wen H; Ting JP
    Mol Cell; 2014 Apr; 54(2):297-308. PubMed ID: 24766894
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Specific inflammasomes in complex diseases.
    Masters SL
    Clin Immunol; 2013 Jun; 147(3):223-8. PubMed ID: 23294928
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inflammasome activation and metabolic disease progression.
    Li HB; Jin C; Chen Y; Flavell RA
    Cytokine Growth Factor Rev; 2014 Dec; 25(6):699-706. PubMed ID: 25156419
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic Opportunities in Damage-Associated Molecular Pattern-Driven Metabolic Diseases.
    Garcia-Martinez I; Shaker ME; Mehal WZ
    Antioxid Redox Signal; 2015 Dec; 23(17):1305-15. PubMed ID: 26055926
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Inflammasome--essential regulator of the inflammatory reaction].
    Junttila I; Meri S; Rämet M
    Duodecim; 2013; 129(7):705-11. PubMed ID: 23720939
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inflammasome activation in response to dead cells and their metabolites.
    Kono H; Kimura Y; Latz E
    Curr Opin Immunol; 2014 Oct; 30():91-8. PubMed ID: 25282339
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A role for the NLRP3 inflammasome in metabolic diseases--did Warburg miss inflammation?
    Wen H; Ting JP; O'Neill LA
    Nat Immunol; 2012 Mar; 13(4):352-7. PubMed ID: 22430788
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inflammasome Priming in Sterile Inflammatory Disease.
    Patel MN; Carroll RG; Galván-Peña S; Mills EL; Olden R; Triantafilou M; Wolf AI; Bryant CE; Triantafilou K; Masters SL
    Trends Mol Med; 2017 Feb; 23(2):165-180. PubMed ID: 28109721
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The inflammasome in atherosclerosis and type 2 diabetes.
    Masters SL; Latz E; O'Neill LA
    Sci Transl Med; 2011 May; 3(81):81ps17. PubMed ID: 21543720
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Innate immune receptors: key regulators of metabolic disease progression.
    Jin C; Henao-Mejia J; Flavell RA
    Cell Metab; 2013 Jun; 17(6):873-882. PubMed ID: 23747246
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Damage-associated molecular patterns and their pathological relevance in diabetes mellitus.
    Shin JJ; Lee EK; Park TJ; Kim W
    Ageing Res Rev; 2015 Nov; 24(Pt A):66-76. PubMed ID: 26197086
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NLRP3 inflammasomes link inflammation and metabolic disease.
    De Nardo D; Latz E
    Trends Immunol; 2011 Aug; 32(8):373-9. PubMed ID: 21733753
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent insights on modulation of inflammasomes by adipokines: a critical event for the pathogenesis of obesity and metabolism-associated diseases.
    Pham DV; Park PH
    Arch Pharm Res; 2020 Oct; 43(10):997-1016. PubMed ID: 33078304
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Emerging inflammasome effector mechanisms.
    Lamkanfi M
    Nat Rev Immunol; 2011 Mar; 11(3):213-20. PubMed ID: 21350580
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inflammasome Signaling and Other Factors Implicated in Atherosclerosis Development and Progression.
    Nazarian-Samani Z; Sewell RDE; Rafieian-Kopaei M
    Curr Pharm Des; 2020; 26(22):2583-2590. PubMed ID: 32364068
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gut Microbiota as a Trigger for Metabolic Inflammation in Obesity and Type 2 Diabetes.
    Scheithauer TPM; Rampanelli E; Nieuwdorp M; Vallance BA; Verchere CB; van Raalte DH; Herrema H
    Front Immunol; 2020; 11():571731. PubMed ID: 33178196
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nutritional modulation of metabolic inflammation.
    Kirwan AM; Lenighan YM; O'Reilly ME; McGillicuddy FC; Roche HM
    Biochem Soc Trans; 2017 Aug; 45(4):979-985. PubMed ID: 28710289
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inflammasomes.
    de Zoete MR; Palm NW; Zhu S; Flavell RA
    Cold Spring Harb Perspect Biol; 2014 Oct; 6(12):a016287. PubMed ID: 25324215
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pacific Populations, Metabolic Disease and 'Just-So Stories': A Critique of the 'Thrifty Genotype' Hypothesis in Oceania.
    Gosling AL; Buckley HR; Matisoo-Smith E; Merriman TR
    Ann Hum Genet; 2015 Nov; 79(6):470-80. PubMed ID: 26420513
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inflammasome as a New Therapeutic Target for Diabetic Complications.
    Volpe CM; Anjos PM; Nogueira-Machado JA
    Recent Pat Endocr Metab Immune Drug Discov; 2016; 10(1):56-62. PubMed ID: 26899852
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.